Market Place
Sourcing Support
Sunshine Biopharma Strengthens Executive Leadership Team
15 Jan 2025 //
ACCESSWIRE
Sunshine Biopharma Launches a New Generic Prescription Drug
04 Dec 2024 //
ACCESSWIRE
Sunshine Biopharma Announces K1.1 mRNA Product for Liver Cancer
02 Dec 2024 //
ACCESSWIRE
Sunshine Biopharma Launches a New Generic Prescription Drug
22 Nov 2024 //
ACCESSWIRE
Sunshine Biopharma Reports Q3 2024 Results, Revenues Up 54%
06 Nov 2024 //
ACCESSWIRE
Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024
26 Aug 2024 //
ACCESSWIRE
Sunshine Biopharma Reports Q2 Revenue Up 67%, YTD Up 61%
19 Aug 2024 //
ACCESSWIRE
Sunshine Biopharma Announces Reverse Stock Split
06 Aug 2024 //
ACCESSWIRE
Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%
21 May 2024 //
ACCESSWIRE
Sunshine`s Nora Pharma Gets Health Canada Nod For Neulasta Biosimilar
19 Apr 2024 //
ACCESSWIRE
Sunshine Reports Operating Results for the Fiscal Year Ended December 31, 2023
01 Apr 2024 //
ACCESSWIRE
Sunshine Bio Announces Closing of $10.0 Million Underwritten Public Offering
15 Feb 2024 //
ACCESSWIRE
Sunshine Announces Pricing of $10.0 Million Underwritten Public Offering
13 Feb 2024 //
ACCESSWIRE
Sunshine Biopharma Moves Principal Office to New York City
04 Dec 2023 //
GLOBENEWSWIRE
Sunshine Biopharma Reports 2023 Third Quarter Results
13 Nov 2023 //
ACCESSWIRE
Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%
11 Aug 2023 //
GLOBENEWSWIRE
Sunshine Biopharma Announces Closing of $5.0 m Private Placement Priced
16 May 2023 //
GLOBENEWSWIRE
Sunshine Announces Pricing of $5.0M Private Placement Priced At-the-Market
12 May 2023 //
GLOBENEWSWIRE
Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%
11 May 2023 //
GLOBENEWSWIRE
Sunshine Reports Full Year Ended December 31, 2022 Financial Results
05 Apr 2023 //
GLOBENEWSWIRE
Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona
28 Feb 2023 //
GLOBENEWSWIRE
Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital
10 Feb 2023 //
GLOBENEWSWIRE
Sunshine Biopharma Announces Share Repurchase Program
19 Jan 2023 //
GLOBENEWSWIRE
Sunshine Biopharma’s Annual Letter to Shareholders
20 Dec 2022 //
GLOBENEWSWIRE
Sunshine Enters Into a Collab Agreement with a Lipid Nanoparticle Formulation
16 Nov 2022 //
GLOBENEWSWIRE
Sunshine Biopharma Announces the Acquisition of Nora Pharma
20 Oct 2022 //
BIOSPACE
Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research
28 Jul 2022 //
GLOBENEWSWIRE
Sunshine Generic Brivaracetam Receives Approval in the U.S.
09 Jun 2022 //
FDA
Sunshine Biopharma Announces Closing of $19.5M Private Placement
28 Apr 2022 //
GLOBENEWSWIRE
Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA
25 Apr 2022 //
GLOBENEWSWIRE
Why Is Sunshine Biopharma (SBFM) Stock Down 30% Today?
08 Apr 2022 //
FXSTREET
Sunshine`s mRNA Molecules Effective Against Multidrug Resistant Cancer Cells
05 Apr 2022 //
GLOBENEWSWIRE
Sunshine Biopharma Announces Closing of $8M Private Placement
14 Mar 2022 //
GLOBENEWSWIRE
Sunshine Biopharma says Pricing of $8M Private Placement Priced At-the-Market
10 Mar 2022 //
GLOBENEWSWIRE
Sunshine Biopharma inks agreement with University of Arizona for covid programme
28 Feb 2022 //
PHARMABIZ
Sunshine Biopharma Expands Anti-Coronavirus Drug Development Program
25 Feb 2022 //
GLOBENEWSWIRE
Sunshine Biopharma Closes $8M Public Offering and Uplisting to Nasdaq
17 Feb 2022 //
GLOBENEWSWIRE
Sunshine Biopharma Announces Pricing of $8M Public Offering
15 Feb 2022 //
GLOBENEWSWIRE
Sunshine Biopharma Files a Patent Application Covering mRNA Molecules
06 Oct 2021 //
GLOBENEWSWIRE
Sunshine`s Generic Linagliptin Receives Approval in the US
31 Aug 2021 //
FDA
Sunshine`s Generic Linagliptin & Metformin HCl Receives Approval in the US
30 Aug 2021 //
FDA
Sunshine Biopharma Receives $0.9 Million in Additional Funding From RB Capital
20 Jul 2021 //
GLOBENEWSWIRE
Sunshine Biopharma Employs mRNA Vaccine Technology
08 Jul 2021 //
GLOBENEWSWIRE
Sunshine Biopharma’s Adva-27a Destroys Cancer Cells Expressing P-glycoprotein,
25 May 2021 //
GLOBENEWSWIRE
Sunshine Biopharma Receives NOA for a New Patent Application Adva-27a
11 Mar 2021 //
GLOBENEWSWIRE
Sunshine Biopharma Signs Exclusive License Agreement With University
04 Feb 2021 //
BIOSPACE
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application
02 Feb 2021 //
BIOSPACE
